Ginsenosides in Liver Fibrosis: Pharmacological Actions and Therapeutic Potential
Na Li(Shenzhen Third People’s Hospital), Xiaoyu Hu(Chengdu University of Traditional Chinese Medicine), Liyuan Hao(Chengdu University of Traditional Chinese Medicine), Qing Peng(Peking University), Fei Yu(Chengdu University of Traditional Chinese Medicine), Shenghao Li(Hebei Medical University), Fanghang Ye(Chengdu University of Traditional Chinese Medicine), Junli Zhang(Bengbu Medical College), Jiali Deng(Chinese Academy of Sciences)
Cited by 0
Related Papers
Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test
|Annals of Translational Medicine|2020|161
Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test
|medRxiv|2020|97
Bclaf1 is an important NF-κB signaling transducer and C/EBPβ regulator in DNA damage-induced senescence
|Cell Death and Differentiation|2016|80
Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson’s disease via inhibiting oxidative stress and ferroptosis
|BMC Complementary Medicine and Therapies|2023|73
The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
|Journal of Inflammation Research|2024|61